Skip to main content
. 2015 May 19;34(8):1693–1699. doi: 10.1007/s10096-015-2406-x

Fig. 1.

Fig. 1

Clinical efficacy of treatment groups. Comparison of clinical outcomes between piperacillin/tazobactam (TZP) [white bar] and amoxicillin plus temocillin (AMX+TMO) [black bar] groups. No significant difference was observed